Jupiter Neurosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Jupiter, FL
JUNS chart
What traders are saying about $JUNS
Latest postsJupiter Neurosciences, Inc. news
- A Tiny Psychedelic Stock Just Exploded Over 50% – Retail Traders Think $1 Is Next
Stocktwits ·
- Sector Update: Healthcare Stocks Mixed Late Afternoon
Yahoo Finance ·
- Sector Update: Healthcare Stocks Mixed Tuesday Afternoon
Yahoo Finance ·
- Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
Yahoo Finance ·
- Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Yahoo Finance ·
- Real Parkinson’s Disease Hope from Jupiter Neurosciences
Yahoo Finance ·
- Jupiter Neurosciences, Inc. Announces Reverse Stock Split
Yahoo Finance ·
- Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
Yahoo Finance ·
- Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS)
investorshub.advfn.com ·
- Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
Yahoo Finance ·
- PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
Yahoo Finance ·
- Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson
Yahoo Finance ·
Jupiter Neurosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $21,796 | – | – |
| Net income | -$8.6M | -$2.4M | -$4.8M |
| Diluted EPS | $-0.25 | $-0.08 | $-0.18 |
| Total assets (year end) | $5.6M | $6.2M | $148,592 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Jupiter Neurosciences, Inc.
- Ticker
- JUNS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Jupiter, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1679628
- Former names
- Jupiter Orphan Therapeutics, Inc.
Frequently asked questions
What exchange is Jupiter Neurosciences, Inc. listed on?
Jupiter Neurosciences, Inc. trades on the Nasdaq under the ticker symbol JUNS.
What industry is Jupiter Neurosciences, Inc. in?
Jupiter Neurosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Jupiter Neurosciences, Inc. headquartered?
Jupiter Neurosciences, Inc.'s business address on file with the SEC is in Jupiter, FL.
When does Jupiter Neurosciences, Inc.'s fiscal year end?
Jupiter Neurosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Jupiter Neurosciences, Inc. report?
Jupiter Neurosciences, Inc. reported $21,796 in revenue for calendar year 2025, according to its SEC filings.